Thyroid hormones (TH) are known to regulate endochondral ossification during skeletal development via acting directly in chondrocytes and osteoblasts. In this study, we focused on TH effects on the secondary ossification center (SOC), since the time of appearance of SOCs in several species coincides with the time when peak levels of TH are attained. Accordingly, µCT evaluation of femurs and tibias at day 21 in TH-deficient and control mice revealed that endochondral ossification of SOCs is severely compromised due to TH deficiency and that TH treatment for 10 days completely rescued this phenotype. Staining of cartilage and bone in the epiphysis revealed that while all of the cartilage is converted into bone in the prepubertal control mice, this conversion failed to occur in the TH-deficient mice. Immunohistochemistry studies revealed that TH treatment of Tshr -/-mice induced expression of Ihh and Osx in Col2 expressing chondrocytes in the SOC at day 7 which subsequently differentiate into Col10/osteocalcin expressing chondro-osteoblasts at day 10. Consistent with these data, treatment of tibia cultures from 3-day old mice with10 ng/ml TH increased expression of Osx, Col10, ALP and osteocalcin in the epiphysis by 6-60 fold. Furthermore, knockdown of the TH-induced increase in Osx expression using lentiviral shRNA significantly blocked TH-induced ALP and osteocalcin expression in chondrocytes. Treatment of chondrogenic cells with an Ihh inhibitor abolished chondro-osteoblast differentiation and SOC formation. Our findings indicate that TH regulates the SOC initiation and progression via differentiating chondrocytes into bone matrix producing osteoblasts by stimulating Ihh and Osx expression in chondrocytes.
INTRODUCTION
In mammals, longitudinal skeletal growth of endochondral bones occurs rapidly in embryonic and early postnatal life. Longitudinal growth slows until pubertal growth when the skeletal growth rate again briefly increases (1) .
Longitudinal skeletal growth is a result of proliferation and differentiation of chondrocytes at the growth plate (2) (3) (4) . During endochondral ossification, osteoprogenitors inside mesenchymal condensations differentiate into chondrocytes, forming a cartilage template that is subsequently replaced by mineralized bone (2, 5, 6) . The perichondrial cells surrounding the cartilage are derived from the differentiation of condensed mesenchymal cells into osteoblasts which contribute to the development of compact bone via an intramembranous bone formation process (2) (3) (4) (5) (6) . The development of bone from a cartilaginous scaffold involves formation of both a primary ossification center (POC) and a secondary ossification center (SOC). It has been established that POCs form at E15.5 during mouse embryonic development. SOCs normally begin to form sometime later, primarily after birth, around murine postnatal days 5 to 7 (7) . It is now generally accepted that the ossification of POCs begins with the formation of a mineralized bony collar around the nascent bone midshaft followed by hypertrophy of the local cartilage, proceeding with invasion of capillaries, calcification of the extracelluar matrix, initiation of osteoclastic cell resorption, and further replacement of the cartilaginous matrix with a bone matrix (2) (3) (4) (5) (6) . Endochondral ossification at POCs is known to be tightly regulated by the combined actions of a number of growth factors (PTHrp, Ihh, IGF-I, BMP/TGFβ, Wnt, VEGF), and transcription factors (Sox9, Runx2, Osterix, β-catenin) (2) (3) (4) (5) (6) (8) (9) (10) (11) (12) . Dysregulation in the production and/or actions of any of the growth factors that regulate endochondral ossification results in skeletal diseases including chondrodysplasias and osteoarthritis (5, 10, 13) .
Both POC and SOC processes involve establishment of growth plates and resorption of cartilage for replacement with bone. However there are important distinctions between them; the timing, the location of the cartilage template, as well as the direction through which ossification proceeds are distinctly different (7, 14, 15) .
The interaction between Ihh and PTHrp has been considered to play a key role in the transition from pristine cartilage to advancing bone during POC formation (16) (17) (18) . However, the nature of these and other regulatory 4 molecules, and their signaling pathways, as well as the cellular processes that contribute to the initiation and progression of SOC formation remains poorly understood.
Thyroid hormones (TH), triiodothyronine (T 3 ) and thyroxine (T 4 ), play an important role in normal endochondral ossification during skeletal development, linear growth, maintenance of bone mass and efficient fracture healing (19) (20) (21) (22) . The major form of thyroid hormone in the blood is T 4 , which has a longer half-life than T 3 . T 4 is converted to active T 3 within cells by deiodinases (5'-iodinase). Juvenile hypothyroidism causes growth arrest with delayed bone formation and mineralization while TH replacement induces rapid catch-up growth (19) (20) (21) (22) . By contrast, childhood thyrotoxicosis accelerates bone formation, with premature closure of the growth plates and skull sutures, leading to short stature and craniosynostosis (19) (20) (21) (22) . Our recent studies using mice with a combination of TH and growth hormone (GH) deficiencies have provided unequivocal evidence that there is an important window in time, prior to puberty, when the effects of GH are surprisingly small, and that instead TH plays a critical role in the continuing regulation of skeletal development and growth (22) . It is of interest that the time of appearance of SOCs in several species including mice, rats, and humans coincides with the time when peak levels of TH are measured (23) (24) (25) (26) (27) (28) . In humans the identification of proximal humeral epiphsyeal secondary ossification centers coincides with the attainment of peak levels of circulating TH, occurring in the late third trimester-early postnatal period (36-42 weeks) (23, 26, 27) . Since the postnatal rise of TH in mice occurs between days 5-14 , a time of heightened SOC activity, a developmental period considered equivalent to the comparable human late third trimester-early postnatal period (29, 30) , it is hypothesized that the rise in TH is a contributing factor to the initiation and progression of secondary ossification in both animals and humans. In this study, we evaluated the role, and mechanism of action, of TH in the initiation and progression of SOC formation in TH deficient mice. Our findings provide the first experimental evidence that the rise in serum TH level during the murine prepubertal growth period (days 5-14) directly initiates SOC activity, by promoting conversion of osterix expressing chondrocytes into bone matrix producing chondro/osteoblasts via a hedgehog signaling pathway.
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MATERIALS AND METHODS
Chemicals, recombinant proteins and biological reagents: T3 and T4 were purchased from Sigma (Saint Louis, MO). Pre-made lentiviruses expressing small hairpin RNA (shRNA) specifically against Osx and GFP, and specific antibodies to mouse osterix (Osx) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The chondrogenic cell line ATDC5 derived from teratocarcinoma AT805 was purchased from the American Type Culture Collection (Manassas, VA).
Mouse models: Tshr +/-heterozygous mice with a point mutation in the coding region of the thyroid stimulating hormone receptor (Tshr) gene was purchased from the Jackson Laboratory (Bar Harbor, Maine). Osterix-cherry reporter mice were kindly provided by Dr. Peter Maye at the University of Connecticut Health Center (31) . Both male and female mice in approximately equal numbers were used and the data from both newborn genders were pooled for analyses. Mice were housed at the Jerry L. Pettis Memorial VA Medical Center Veterinary Medical Unit (Loma Linda, CA) under standard approved laboratory conditions. All the procedures were performed with the approval of the Institutional Animal Care and Use Committee of the Jerry L Pettis Memorial VA Medical Center.
Mice were anesthetized with approved anesthetics (Isoflurane, ketamine/xylazine) prior to procedures. For euthanasia, animals were exposed to CO 2 prior to cervical dislocation.
Skeleton staining: Alizarin red staining of the long bones from 14 day old Tshr -/-and Tshr +/-mice was performed using an established method (32) .
TH rescue experiments: Tshr
-/-mice were injected intraperitoneally with a combination of 1 μg T3 and 10 μg of T4 daily for 10 days from day 5 to day 14 or the same volume of vehicle (5 mM NaOH). Littermate Tshr +/-mice treated with vehicle were used as controls. At different times after initiation of T3/T4 treatment, mice were euthanized; bones were removed and used for various analyses.
Histological Analyses: Mouse tibias and femurs were fixed in 10% formalin overnight, washed, decalcified in 10% EDTA (pH 7.4) at 4 0 C for 7 days with shaking and embedded in paraffin for sectioning. Consecutive sections of the proximal tibia epiphyses and growth plates were stained with trichrome and Safranin-O, respectively. Two 6 images from 2 longitudinal sections with 5 sections apart from the middle of tibias were taken for quantification.
The histological measurements of bone area, total area, growth plate thickness, and hypertrophic region were made as described previously in a blinded fashion with computer software OsteoMeasure (OsteoMetrics, Decatur, GA) (33, 34) . An average of two image quantifications per animal was used. The magnification of the images is 40 times (4 x 10 = 40).
Immunohistochemistry analyses:
Immunohistochemistry was performed using a rabbit immunohistochemistry kit Micro-CT evaluation of the secondary ossification centers: Trabecular bone microarchitecture of the tibia epiphyses (i.e. the secondary ossification centers) isolated from 21 day old mice were assessed by micro-CT (viva CT40, Scanco Medical AG, Switzerland) as described previously (35, 36) . The femurs and tibias were fixed in 10% formalin overnight, washed with PBS and immersed in PBS to prevent them from drying. Samples were scanned in phosphate buffered saline (pH 7.4). The X-ray tube potential was 70 kVp for cortical bone and 45 kVp for trabecular bone. Vovel size was 10.5 µm 3 . The selected region of interest (ROI) was 1.05 mm of the epiphysis above the growth plate as described in the guidelines (37 ), trabecular thickness (Tb.Th, μm) and trabecular space (Tb.Sp, μm) were evaluated as described previously (35) (36) (37) .
Cell culture: ATDC5 cells were maintained in DMEM/F12 medium containing 10% FBS, penicillin (100 units/ml), and streptomycin (100 μg/ml) as described (38) . Cells were incubated in the presence of serum-free DMEM/F12 medium containing 0.1% bovine serum albumin (BSA) and antibiotics for 24 h prior to treatment with T3, vehicle or cyclopamine. At different times, cultures were terminated and used for various analyses.
Nodule assay and ALP staining: ATDC5 cells were maintained in a DMEM-F12 mineralization medium containing 10 mM -glycerophosphate, 50 µg/ml ascorbic acid and 5% FBS with or without T3 for 7 and 24 days, respectively, prior to staining for ALP activity and mineralized nodules as described (39, 40) .
Transduction in chondrogenic cells: For knockdown studies, ATDC5 cells were transduced with pre-made
Lenti-viral particles expressing shRNA against mouse Osx or control GFP in 6-well culture plates in the presence of 8 µg/ml of polybrene, as described by the manufacturer. Twenty four hours later, the cells were cultured in a fresh osteoblast differentiation medium and treated with T3 or vehicle, followed by RNA extraction for real-time
RT-PCR.
Mouse tibia bone culture: Tibias were surgically isolated from 2-day old C57BL/6 mice and were incubated in serum-free αMEM containing 0.5% BSA, 50 µg/ml ascorbic acid, 1 mM β-glycerol phosphate, 100 units/ml penicillin and 100 µg/ml streptomycin at 37 0 C in humidified air with 5% CO 2 as reported (41) . T3 (10 ng/ml) or the same volume of vehicle control was added to medium 1 day later, bones were cultured for 10 days for RNA extraction and real-time RT-PCR.
RNA extraction and quantitative PCR: RNA was extracted from ATDC5 cells as described previously (36).
Epiphysis and growth plate regions of long bones were isolated and ground to powder in liquid nitrogen using a mortar and pestle prior to RNA extraction. An aliquot of RNA (25 ng) was reverse-transcribed with an oligo (dT) 12-18 primer into cDNA in a 20 µl reaction volume. The real time PCR reaction contained 0.5 µl of template 8 cDNA, 1x SYBR GREEN master mix (ABI), and 100 nM of specific forward and reverse primers in a 25 l reaction volume. Primers for peptidyl prolyl isomerase A (PPIA) was used to normalize the expression data for the genes of interest. The primer sequences used for real-time PCR are listed in supplementary Table 2 .
Statistical Analysis: Data are presented as the mean  standard error of means (SEM) from 6-10 mice from each group. Significant difference was determined as P ≤ 0.05 or P ≤ 0.01. Data were analyzed by Student's t-test or two-way ANOVA as appropriate. mice, but was restored to a normal level after TH treatment (Fig. 4E) . In agreement with the morphological changes in the epiphyses, the growth plates in Tshr -/-mice were thinner than in heterozygous mice (Fig. 2E, F (Fig, 3) . The collagen 2 expression remained high at day 10 in the epiphyses of the proximal tibia of Tshr Consistent with the immunohistochemistry data, TH injection of osterix-cherry reporter mice at day 5 and 6 caused robust expression of the Osx cherry reporter gene in the SOC at day 10 ( Fig. 4B) . Interestingly, the Col2 expressing cells at the edge of the SOC expressed high levels of Osx, Col10, and OC at day 10 while the ossification center was forming bone matrix (Fig. 4C) . Transcript levels of Osx and OC in the tibia and femurs isolated from Tshr -/-mice were reduced compared to the bones from heterozygous control mice, as measured by real-time RT-PCR. (Fig. 4D) . Histology analyses revealed reduced expression of TRAP in the SOC of mutant mice (Fig. 4E) .
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RESULTS
TH deficiency in
To further examine the genes that are regulated by TH, we extracted total RNA from the epiphyses of 7 day old mice as compared to the corresponding epiphyses of heterozygous control mice (Fig. 5A, B, C, D) . Transcription factors (Runx2, Osx, β-catenin, Sox6, Sox9, Gli2 and Mef2C) and extracellular signaling molecules (Ihh, IGF-I, RANKL) were dramatically down regulated in the SOC of Tshr -/-mice (Fig. 5E, F, G) . TH treatment of Tshr Fig. 4 ).
Ihh is one of the key signaling molecules controlling both chondrocyte hypertrophy and bone formation in the developing skeletal system. In order to determine if the TH effect on Ihh expression is direct, we evaluated the effect of TH treatment on expression levels of Ihh and its targets using serum-free tibia cultures derived from 3-day old mice. Treatment with TH for 24 and 72 hours increased the expression of Ihh in the epiphyses by 2-and 12-fold, respectively (Fig. 5H) . In fact, TH-induced Ihh expression could be detected at 6 hours after TH treatment (Supplementary Fig. 5 ). Increased expression of Osx and ALP was observed as early as 24 hours after T3 treatment, and higher levels were reached at 72 hours. The expression of chondro/osteoclast markers, Col10 and
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OC were significantly increased after 72 hours of TH treatment when Col2 expression was lower. Sox6 expression was reduced at both 24 and 72 hour time points (Fig. 5H) .
TH effect on chondro/osteoblast differentiation is dependent on Osx expression.
To determine if TH treatment induces differentiation of chondrocytes into chondro/osteoblasts in vitro, we cultured ATDC5 chondrogenic cells in an osteoblast differentiation medium containing 50 µg/ml ascorbic acid and 100 mM β-glycophosphate, and treated cells with TH or vehicle for 6 days prior to ALP staining. We found that ALP positive cells were increased by 8-fold upon TH treatment (Fig. 6A) . Interestingly, a time-course study found that
Osx expression was increased by 3-fold after 24 hours of TH treatment, and remained elevated at day 3 and 7.
ALP expression was highest at day 3 while OC expression was highest at day 7 (Fig. 6B) . Consistent with these data, 24 day TH treatment of ATDC5 cells in an osteoblast differentiation medium resulted in a significant increase in nodule formation (Fig. 6C) . To examine if the increased expression of Osx regulates ATDC5 cell differentiation into chondro/osteoblasts, we transduced ATDC5 cells with lenti-virus expressing shRNA specific to mouse osterix or control GFP. We observed that knockdown of the TH-induced increase in Osx expression significantly blocked TH-induced expression of ALP and OC, and reduced ALP activity in ATDC5 cells (Fig. 6D, E, F, G) .
Ihh signaling is required for TH induction of Osx expression and chondro/osteroblast differentiation.
To determine if Ihh signaling is involved in regulating TH induction of Osx expression, we examined the effects of cyclopamine, a known inhibitor of hedgehog signaling, on Osx expression in ATDC5 cells. We found that cyclopamine treatment not only blocked the TH-induced increase in Osx, but also the TH effects on the Col10 mRNA level (Supplementary Fig. 6A& C) . ALP expression was reduced by 85% in both control and T3 treated cells upon cyclopamine treatment (Supplementary Fig. 6B ). To further confirm the role of Ihh signaling in Osx expression, we cultured tibias from 3 day old mice in vitro and treated the bones with TH in the presence or absence of cyclopamine for 3 days prior to RNA extraction and real-time PCR. In agreement with ATDC5 cell culture data, we found that suppression of Ihh signaling using cyclopamine abolished Osx, ALP, Col10, Ptch1, and Gli1 expression in primary epithyseal chondrocytes (Fig. 7A, , C, D, E) . While treatment of tibia cultures with cyclopamine did not completely abolish TH-induction of OC expression, the expression was reduced from 9 fold to 13 6 fold (Fig. 7B) . Consistent with the in vitro studies, treatment of Tshr +/-heterozygous mice with cyclopamine reduced bone volume, trabecular number, but increased trabecular spacing of the tibia epiphyses (Fig. 7E, F, G,   H) . Thus, our data support that TH regulates SOC initiation and progression via stimulating differentiation of chondrocytes into bone matrix producing osteoblasts by increasing Ihh expression and subsequently Osx expression in epiphyseal chondrocytes.
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DISCUSSION
In humans and animals, the postnatal linear skeletal growth rate declines dramatically with age until the pubertal growth spurt when the growth rate briefly increases (1). This deceleration of longitudinal growth in bone during the prepubertal growth period is accompanied by a corresponding increase in the rate of gain in BMD, which is caused by a gradual replacement of cartilage with mineralized bone, at SOCs by an endochondral ossification process, providing the necessary mechanical support for the developing organism (2, 12, 42) . While a number of systemic mechanisms involving GH, TH, glucocorticoids, sex hormones, and nutrition have been implicated in regulating SOC endochondral ossification, the key molecular signals that initiate and drive the SOC formation process are unknown. Our data point out that the SOC is severely compromised in TH deficient Tshr -/-mice, and that the SOC delay defect is completely rescued by T3/T4 treatment during a window of time when serum levels of TH naturally increase during postnatal growth. Our data provide direct evidence for a key role for circulating TH in the initiation and progression of SOC formation (22).
We and others have shown that TH exerts direct effects on bone cells and that TH deficiency influences development of peak bone mass in both animals and humans (20) (21) (22) . In this study, we provide the first direct experimental evidence that the rapid increase in TH level that occurs during the second week of postnatal life in mice is obligatory for initiation and progression of SOC activity. The severely compromised bone volume in the epiphysis of Tshr -/-mice is completely rescued by TH replacement, administered during postnatal days 5-14, demonstrating that the initiation and progression of endochondral bone formation at SOC sites is a direct consequence of the increase in TH level, particularly during the prepubertal growth period. In humans, the identification of a proximal humeral epiphyseal ossification center occurs around a gestational age of 38 weeks which also coincides with the attainment of peak circulating level of TH (23, 26, 27) , thus predicting a similar role for TH in SOC formation in humans.
While the molecular mechanisms that contribute to the formation of POCs during embryonic development have been extensively investigated, little is known about the cellular processes involved in postnatal SOC development and activity. The prevailing model for endochondral ossification at POCs dictates that proliferating chondrocytes mature into hypertrophic chondrocytes producing mineralized cartilage, and promoting vascularization and remodeling (3, 8, 11, 12, 23, 26, 27, (43) (44) (45) . Subsequent to the death of chondrocytes, the invading blood vessels are believed to contribute to the source of osteoblast precursors which differentiate into mature osteoblasts and lay down bone matrix (46) . However there are important distinctions between POC and SOC activity. POC endochondral bone formation proceeds in a single direction from the center of the diaphysis to the metaphysis with a fairly uniform speed for a relatively long period during primary ossification. By contrast, SOC is known to involve formation of cartilage canals, leading to initiation of ossification in the middle of the epiphysis, which then progresses in a centrifugal-radial pattern during a short period (47, 48 Previous studies have shown that Osx is required for osteoblast differentiation and bone formation during embryonic development as well as in growing and adult bones (51) (52) (53) . While these studies focused on the role of Osx expressed in osteoblastic lineage cells in skeletal development, it has recently become known that Osx is also expressed in chondrocytes at certain stages during development and that mice with disruption of Osx in Col2 expressing chondroyctes fail to thrive after birth due to defects in skeletal maturation (54) . Consistent with a role A key early event in SOC formation is removal of cartilaginous matrix for replacement in bone matrix. In this regard, expression of MMPs, notably, MMP13 and MMP14, have been detected in the epiphysis and have been shown to play a key role in eroding epiphyseal cartilage (65, 66) . We, therefore, asked the question whether
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TH is involved in regulating expression of MMPs in epiphyseal chondrocytes. We found that expression levels of both MMP13 and MMP14 were decreased in the epiphysis of Tshr -/-mice that were rescued by treatment with TH. By contrast, the expression level of Ctsk, a marker of differentiated osteoclasts, was not affected. Furthermore, T3
treatment caused a significant increase in MMP13 in the epiphysis of serum-free tibia cultures. It remains to be determined whether the TH effect on MMP expression is directly or indirectly mediated via the TH effect on RANKL/OPG expression in epiphyseal chondrocytes.
Based on our data, we conclude that the rapid increase in TH levels during the prepubertal growth period in mice acts directly on epiphyseal chondrocytes modulating expression of key growth factors, altering the activity of transcription factors inhibiting Col2 expression, promoting secretion of enzymes for cartilaginous matrix removal, and by influencing the expression of osteoblast marker proteins involved in actively mineralizing the receptive bone cartilage (Fig. 8) . Furthermore our data strongly implicates epiphyseal chondrocytes themselves as being independently capable of carrying out many of these processes. Thus, our data challenges the existing paradigm that similar mechanisms are operative in the POC and SOC processes. Our data indicate that the conversion of chondrocytes into chondro/osteoblasts may occur only during secondary ossification when TH levels rise. 
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